These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12831323)

  • 21. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
    Stoehlmacher J; Goekkurt E; Lenz HJ
    Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticles and microparticles for skin drug delivery.
    Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
    Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural pharmacogenomics: the answer to antimicrobial drug resistance?
    Taylor PW; Stapleton PD
    Drug Discov Today; 2003 Feb; 8(3):110-1. PubMed ID: 12568777
    [No Abstract]   [Full Text] [Related]  

  • 25. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 26. Fundamentals and applications of pharmacogenetics for the clinical laboratory.
    Linder MW; Valdes R
    Ann Clin Lab Sci; 1999; 29(2):140-9. PubMed ID: 10219702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics and forensic toxicology.
    Musshoff F; Stamer UM; Madea B
    Forensic Sci Int; 2010 Dec; 203(1-3):53-62. PubMed ID: 20828952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of RAGE and GECKO in cell-based target discovery screens.
    Brunden K; Sherf B; Harrington J
    Pharmacogenomics; 2005 Jun; 6(4):383-92. PubMed ID: 16004556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human pharmacogenomic variations and their implications for antifungal efficacy.
    Meletiadis J; Chanock S; Walsh TJ
    Clin Microbiol Rev; 2006 Oct; 19(4):763-87. PubMed ID: 17041143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of opioid analgesics in dogs.
    Kongara K
    J Vet Pharmacol Ther; 2018 Apr; 41(2):195-204. PubMed ID: 28892154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic medicines for oncology: early lessons.
    Simons JW
    J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904
    [No Abstract]   [Full Text] [Related]  

  • 32. Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies.
    Lonetti A; Fontana MC; Martinelli G; Iacobucci I
    Methods Mol Biol; 2016; 1368():143-59. PubMed ID: 26614074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics, pharmacogenomics and airway disease.
    Hall IP
    Respir Res; 2002; 3(1):10. PubMed ID: 11806845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albumin: a versatile carrier for drug delivery.
    Park K
    J Control Release; 2012 Jan; 157(1):3. PubMed ID: 22119742
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug delivery systems for differential release in combination therapy.
    Zhang H; Wang G; Yang H
    Expert Opin Drug Deliv; 2011 Feb; 8(2):171-90. PubMed ID: 21226651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental and pediatric pharmacogenomics.
    Leeder JS
    Pharmacogenomics; 2003 May; 4(3):331-41. PubMed ID: 12718723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticulate drug delivery systems for cancer chemotherapy.
    Saha RN; Vasanthakumar S; Bende G; Snehalatha M
    Mol Membr Biol; 2010 Oct; 27(7):215-31. PubMed ID: 20939772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.